Synthesis, molecular docking study and anticancer activity of novel 1,3,4-oxadiazole derivatives as potential tubulin inhibitors

The current study reports on the synthesis and anticancer efficacy of novel oxadiazole derivatives (8a-f) as tubulin polymerization inhibitors. NMR, mass, and elemental studies were used to confirm the newly produced compounds. In contrast to the conventional medicine colchicine, compounds 8e and 8f...

Full description

Bibliographic Details
Main Authors: Tarek A. Yousef, Abdulrahman G. Alhamzani, Mortaga M. Abou-Krisha, G. Kanthimathi, M.S. Raghu, K. Yogesh Kumar, M.K. Prashanth, Byong-Hun Jeon
Format: Article
Language:English
Published: Elsevier 2023-02-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023006679
_version_ 1811161787366637568
author Tarek A. Yousef
Abdulrahman G. Alhamzani
Mortaga M. Abou-Krisha
G. Kanthimathi
M.S. Raghu
K. Yogesh Kumar
M.K. Prashanth
Byong-Hun Jeon
author_facet Tarek A. Yousef
Abdulrahman G. Alhamzani
Mortaga M. Abou-Krisha
G. Kanthimathi
M.S. Raghu
K. Yogesh Kumar
M.K. Prashanth
Byong-Hun Jeon
author_sort Tarek A. Yousef
collection DOAJ
description The current study reports on the synthesis and anticancer efficacy of novel oxadiazole derivatives (8a-f) as tubulin polymerization inhibitors. NMR, mass, and elemental studies were used to confirm the newly produced compounds. In contrast to the conventional medicine colchicine, compounds 8e and 8f demonstrated stronger sensitivity and improved IC50 values in the range of 3.19–8.21 μM against breast MCF-7, colorectal HCT116, and liver HepG2 cancer cell lines. The target compounds were tested for enzymatic activity against the tubulin enzyme. Compounds 8e and 8f were shown to have the most effective inhibitory action among the new compounds, with IC50 values of 7.95 and 9.81 nM, respectively. As compared to the reference drug, molecular docking investigations of the developed compounds revealed the crucial hydrogen bonding in addition to the hydrophobic interaction at the binding site, assisting in the prediction of the structural requirements for the found anticancer activity. These findings indicate that the 1,3,4-oxadizole scaffold has the potential for future research into new anticancer medicines.
first_indexed 2024-04-10T06:19:57Z
format Article
id doaj.art-d18d1f59136c496187e4bedf4713f874
institution Directory Open Access Journal
issn 2405-8440
language English
last_indexed 2024-04-10T06:19:57Z
publishDate 2023-02-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj.art-d18d1f59136c496187e4bedf4713f8742023-03-02T05:01:39ZengElsevierHeliyon2405-84402023-02-0192e13460Synthesis, molecular docking study and anticancer activity of novel 1,3,4-oxadiazole derivatives as potential tubulin inhibitorsTarek A. Yousef0Abdulrahman G. Alhamzani1Mortaga M. Abou-Krisha2G. Kanthimathi3M.S. Raghu4K. Yogesh Kumar5M.K. Prashanth6Byong-Hun Jeon7College of Science, Chemistry Department, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia; Department of Toxic and Narcotic Drug, Forensic Medicine, Mansoura Laboratory, Medicolegal Organization, Ministry of Justice, EgyptCollege of Science, Chemistry Department, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi ArabiaCollege of Science, Chemistry Department, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia; Department of Chemistry, South Valley University, Qena, 83523, EgyptDepartment of Chemistry, Ramco Institute of Technology, Rajapalayam, Tamilnadu, 626117, IndiaDepartment of Chemistry, New Horizon College of Engineering, Bengaluru 560 103, IndiaDepartment of Chemistry, Faculty of Engineering and Technology, Jain University, Ramanagara, 562 112, IndiaDepartment of Chemistry, B N M Institute of Technology, Bengaluru 560 070, India; Corresponding author.Department of Earth Resources and Environmental Engineering, Hanyang University, 222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Republic of Korea; Corresponding author. Department of Earth Resources and Environmental Engineering, Hanyang University, 222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Republic of Korea.The current study reports on the synthesis and anticancer efficacy of novel oxadiazole derivatives (8a-f) as tubulin polymerization inhibitors. NMR, mass, and elemental studies were used to confirm the newly produced compounds. In contrast to the conventional medicine colchicine, compounds 8e and 8f demonstrated stronger sensitivity and improved IC50 values in the range of 3.19–8.21 μM against breast MCF-7, colorectal HCT116, and liver HepG2 cancer cell lines. The target compounds were tested for enzymatic activity against the tubulin enzyme. Compounds 8e and 8f were shown to have the most effective inhibitory action among the new compounds, with IC50 values of 7.95 and 9.81 nM, respectively. As compared to the reference drug, molecular docking investigations of the developed compounds revealed the crucial hydrogen bonding in addition to the hydrophobic interaction at the binding site, assisting in the prediction of the structural requirements for the found anticancer activity. These findings indicate that the 1,3,4-oxadizole scaffold has the potential for future research into new anticancer medicines.http://www.sciencedirect.com/science/article/pii/S24058440230066791,3,4-OxadiazoleAnticancerTubulin inhibitorsMolecular docking
spellingShingle Tarek A. Yousef
Abdulrahman G. Alhamzani
Mortaga M. Abou-Krisha
G. Kanthimathi
M.S. Raghu
K. Yogesh Kumar
M.K. Prashanth
Byong-Hun Jeon
Synthesis, molecular docking study and anticancer activity of novel 1,3,4-oxadiazole derivatives as potential tubulin inhibitors
Heliyon
1,3,4-Oxadiazole
Anticancer
Tubulin inhibitors
Molecular docking
title Synthesis, molecular docking study and anticancer activity of novel 1,3,4-oxadiazole derivatives as potential tubulin inhibitors
title_full Synthesis, molecular docking study and anticancer activity of novel 1,3,4-oxadiazole derivatives as potential tubulin inhibitors
title_fullStr Synthesis, molecular docking study and anticancer activity of novel 1,3,4-oxadiazole derivatives as potential tubulin inhibitors
title_full_unstemmed Synthesis, molecular docking study and anticancer activity of novel 1,3,4-oxadiazole derivatives as potential tubulin inhibitors
title_short Synthesis, molecular docking study and anticancer activity of novel 1,3,4-oxadiazole derivatives as potential tubulin inhibitors
title_sort synthesis molecular docking study and anticancer activity of novel 1 3 4 oxadiazole derivatives as potential tubulin inhibitors
topic 1,3,4-Oxadiazole
Anticancer
Tubulin inhibitors
Molecular docking
url http://www.sciencedirect.com/science/article/pii/S2405844023006679
work_keys_str_mv AT tarekayousef synthesismoleculardockingstudyandanticanceractivityofnovel134oxadiazolederivativesaspotentialtubulininhibitors
AT abdulrahmangalhamzani synthesismoleculardockingstudyandanticanceractivityofnovel134oxadiazolederivativesaspotentialtubulininhibitors
AT mortagamaboukrisha synthesismoleculardockingstudyandanticanceractivityofnovel134oxadiazolederivativesaspotentialtubulininhibitors
AT gkanthimathi synthesismoleculardockingstudyandanticanceractivityofnovel134oxadiazolederivativesaspotentialtubulininhibitors
AT msraghu synthesismoleculardockingstudyandanticanceractivityofnovel134oxadiazolederivativesaspotentialtubulininhibitors
AT kyogeshkumar synthesismoleculardockingstudyandanticanceractivityofnovel134oxadiazolederivativesaspotentialtubulininhibitors
AT mkprashanth synthesismoleculardockingstudyandanticanceractivityofnovel134oxadiazolederivativesaspotentialtubulininhibitors
AT byonghunjeon synthesismoleculardockingstudyandanticanceractivityofnovel134oxadiazolederivativesaspotentialtubulininhibitors